Connection

LEE M ELLIS to Adult

This is a "connection" page, showing publications LEE M ELLIS has written about Adult.
Connection Strength

0.258
  1. Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors. Cancer Prev Res (Phila). 2017 Jul; 10(7):398-409.
    View in: PubMed
    Score: 0.024
  2. MATERNAL ACTIVITY DURING PREGNANCY AND SEXUALLY DIMORPHIC TRAITS IN OFFSPRING. J Biosoc Sci. 2018 Jan; 50(1):114-123.
    View in: PubMed
    Score: 0.024
  3. Familial Depressive Symptoms and Delinquency: Separate Self-Reports From Mothers and Their Offspring. Int J Offender Ther Comp Criminol. 2018 04; 62(5):1201-1215.
    View in: PubMed
    Score: 0.023
  4. Handedness, sexual orientation, and somatic markers for prenatal androgens: Are southpaws really that gay? Laterality. 2017 Mar; 22(2):157-180.
    View in: PubMed
    Score: 0.022
  5. Maternal smoking during pregnancy and self-reported delinquency by offspring. Crim Behav Ment Health. 2012 Dec; 22(5):325-35.
    View in: PubMed
    Score: 0.017
  6. Can inhibition of angiogenic pathways increase the efficacy of intravenous 5-fluorouracil-based regimens? Clin Colorectal Cancer. 2004 Oct; 4 Suppl 2:S69-73.
    View in: PubMed
    Score: 0.010
  7. Population increases in obesity appear to be partly due to genetics. J Biosoc Sci. 2004 Sep; 36(5):547-59.
    View in: PubMed
    Score: 0.010
  8. Feasibility of adjuvant hepatic arterial infusion of chemotherapy after radiofrequency ablation with or without resection in patients with hepatic metastases from colorectal cancer. Ann Surg Oncol. 2003 May; 10(4):348-54.
    View in: PubMed
    Score: 0.009
  9. Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol. 2003 Feb 01; 21(3):421-7.
    View in: PubMed
    Score: 0.009
  10. Overall Survival in Phase 3 Clinical Trials and the Surveillance, Epidemiology, and End Results Database in Patients With Metastatic Colorectal Cancer, 1986-2016: A Systematic Review. JAMA Netw Open. 2022 05 02; 5(5):e2213588.
    View in: PubMed
    Score: 0.008
  11. Trends in Medical Aid in Dying in Oregon and Washington. JAMA Netw Open. 2019 08 02; 2(8):e198648.
    View in: PubMed
    Score: 0.007
  12. Characterizing 18 Years of the Death With Dignity Act in Oregon. JAMA Oncol. 2017 10 01; 3(10):1403-1406.
    View in: PubMed
    Score: 0.006
  13. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015 Feb 15; 21(4):899-906.
    View in: PubMed
    Score: 0.005
  14. Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic. Clin Cancer Res. 2014 Dec 01; 20(23):5956-63.
    View in: PubMed
    Score: 0.005
  15. Pathologic complete response in poorly differentiated adenocarcinomas of the appendix: a case series. Acta Oncol. 2013 Jun; 52(5):1044-6.
    View in: PubMed
    Score: 0.004
  16. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: a matched case-control analysis. Ann Surg Oncol. 2013 Feb; 20(2):482-90.
    View in: PubMed
    Score: 0.004
  17. Genetic polymorphisms in MicroRNA-related genes as predictors of clinical outcomes in colorectal adenocarcinoma patients. Clin Cancer Res. 2012 Jul 15; 18(14):3982-91.
    View in: PubMed
    Score: 0.004
  18. Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. J Clin Oncol. 2010 Jan 20; 28(3):453-9.
    View in: PubMed
    Score: 0.004
  19. Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):824-30.
    View in: PubMed
    Score: 0.003
  20. Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol. 2008 Nov 20; 26(33):5344-51.
    View in: PubMed
    Score: 0.003
  21. Effect of different types of smoking and synergism with hepatitis C virus on risk of hepatocellular carcinoma in American men and women: case-control study. Int J Cancer. 2008 Oct 15; 123(8):1883-91.
    View in: PubMed
    Score: 0.003
  22. Preoperative bevacizumab does not significantly increase postoperative complication rates in patients undergoing hepatic surgery for colorectal cancer liver metastases. J Clin Oncol. 2008 Nov 10; 26(32):5254-60.
    View in: PubMed
    Score: 0.003
  23. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007 Dec 15; 110(12):2761-7.
    View in: PubMed
    Score: 0.003
  24. Vascular spasm during heparin-dihydroergotamine prophylaxis. Clin Pharm. 1987 Jul; 6(7):575-7.
    View in: PubMed
    Score: 0.003
  25. Clinical and in vitro studies of imatinib in advanced carcinoid tumors. Clin Cancer Res. 2007 Jan 01; 13(1):234-40.
    View in: PubMed
    Score: 0.003
  26. Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer. Am J Clin Oncol. 2006 Jun; 29(3):219-24.
    View in: PubMed
    Score: 0.003
  27. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006 Jun; 141(6):537-43; discussion 543-4.
    View in: PubMed
    Score: 0.003
  28. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. J Clin Oncol. 2006 Mar 01; 24(7):1145-51.
    View in: PubMed
    Score: 0.003
  29. Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum. 2006 Feb; 49(2):175-82.
    View in: PubMed
    Score: 0.003
  30. Debunking dogma: surgery for four or more colorectal liver metastases is justified. J Gastrointest Surg. 2006 Feb; 10(2):240-8.
    View in: PubMed
    Score: 0.003
  31. Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis. Ann Surg Oncol. 2005 Aug; 12(8):616-28.
    View in: PubMed
    Score: 0.003
  32. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol. 2004 Sep; 11(9):869-74.
    View in: PubMed
    Score: 0.002
  33. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004 Jun; 239(6):818-25; discussion 825-7.
    View in: PubMed
    Score: 0.002
  34. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 2004 May; 239(5):722-30; discussion 730-2.
    View in: PubMed
    Score: 0.002
  35. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg. 2004 Apr; 239(4):450-8.
    View in: PubMed
    Score: 0.002
  36. Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced rectal carcinoma. J Gastrointest Surg. 2004 Jan; 8(1):56-62; discussion 62-3.
    View in: PubMed
    Score: 0.002
  37. Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg. 2003 Dec; 7(8):1082-8.
    View in: PubMed
    Score: 0.002
  38. Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low rectal carcinoma. Cancer. 2003 Jan 15; 97(2):517-24.
    View in: PubMed
    Score: 0.002
  39. Phase I study of recombinant human endostatin in patients with advanced solid tumors. J Clin Oncol. 2002 Sep 15; 20(18):3792-803.
    View in: PubMed
    Score: 0.002
  40. Development of biologic markers of response and assessment of antiangiogenic activity in a clinical trial of human recombinant endostatin. J Clin Oncol. 2002 Sep 15; 20(18):3804-14.
    View in: PubMed
    Score: 0.002
  41. Simplified staging for hepatocellular carcinoma. J Clin Oncol. 2002 Mar 15; 20(6):1527-36.
    View in: PubMed
    Score: 0.002
  42. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg. 2002 Mar-Apr; 6(2):224-32; discussion 232.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.